Aims and Scope
Atherosclerosis is a monthly peer-reviewed scientific journal established in 1970 and published by Elsevier. It is the official journal of the European Atherosclerosis Society and is affiliated with the International Atherosclerosis Society.
Key Metrics
8.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
186
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.85
5-Year SI
5-year SI
- N/A 2-year SI
- 0.84 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Cardiology and Cardiovascular Medicine
SJR
- Q1 Cardiology and Cardiovascular Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.45
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
15%
4 to 6 months
51%
7 to 9 months
21%
Above 9 months
13%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Inflammation
- Myocardial infarction
- Bone marrow
- Familial hypercholesterolemia
- Computed tomography
- Genotype
- Atherosclerotic cardiovascular disease
- Shear stress
- Blood pressure
- Confidence interval
- Lysyl oxidase
- Coronary artery calcium
- Lipoprotein metabolism
- Machine learning
- Hemodialysis
- Clinical trial
- Sudden death
- Low-density lipoprotein
- Allele
- Percutaneous coronary intervention
Journal Specifications
| Overview | |
| Publisher | ELSEVIER IRELAND LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1961 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Atherosclerosis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Reply to: “Correspondence on: “Subclinical atherosclerosis: More data – More insights into prevention” ”
- 1 Dec 24
- Atherosclerosis
-
Full paper
HDL and cardiovascular risk
- 1 Nov 24
- Atherosclerosis
-
Full paper
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
- 1 Nov 24
- Atherosclerosis
-
Full paper
Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms
- 1 Nov 24
- Atherosclerosis
-
Full paper
PCSK9 inhibitors in the management of atherosclerotic cardiovascular disease: Current clinical trials and future directions
- 1 Nov 24
- Atherosclerosis
-
Full paper
Arterial calcification volume is associated with a higher risk of cardiovascular events in pseudoxanthoma elasticum
- 1 Nov 24
- Atherosclerosis
Scite analysis
Powered by scite_
34.3k articles received 427.3k citations see all
- 24,343 Supporting
- 385,423 Mentioning
- 4,343 Contrasting
Editorial notices
- 4 Retractions
- 6 Withdrawals
- 0 Corrections
- 61 Errata
- 0 Expression of Concern
FAQs
How long has Atherosclerosis been actively publishing?
Atherosclerosis has been in operation since 1961 till date.
What is the publishing frequency of Atherosclerosis ?
Atherosclerosis published with a Monthly frequency.
How many articles did Atherosclerosis publish last years ?
In 2023, Atherosclerosis published 1196 articles.
What is the eISSN & pISSN for Atherosclerosis ?
For Atherosclerosis,eISSN is 1879-1484 and pISSN is0021-9150.
What is Citescore for Atherosclerosis ?
Citescore for Atherosclerosis is 8.7.
What is H index for Atherosclerosis ?
H index for Atherosclerosis is 186.
What is SNIP score for Atherosclerosis ?
SNIP score for Atherosclerosis is 1.45.
What is the SJR for Atherosclerosis ?
SJR for Atherosclerosis is Q1.
Who is the publisher of Atherosclerosis ?
ELSEVIER IRELAND LTD is the publisher of Atherosclerosis.